Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy

Cancer Treat Rev. 2024 Dec:131:102843. doi: 10.1016/j.ctrv.2024.102843. Epub 2024 Oct 15.

Abstract

Natural killer (NK) cells and dendritic cells (DCs) are critical mediators of anti-cancer immune responses. In addition to their individual roles, NK cells and DCs are involved in intercellular crosstalk which is essential for the initiation and coordination of adaptive immunity against cancer. However, NK cell and DC activity is often compromised in the tumor microenvironment (TME). Recently, much attention has been paid to one of the major components of the TME, the cancer-associated fibroblasts (CAFs), which not only contribute to extracellular matrix (ECM) deposition and tumor progression but also suppress immune cell functions. It is now well established that CAFs support T cell exclusion from tumor nests and regulate their cytotoxic activity. In contrast, little is currently known about their interaction with NK cells, and DCs. In this review, we describe the interaction of CAFs with NK cells and DCs, by secreting and expressing various mediators in the TME of adult solid tumors. We also provide a detailed overview of ongoing clinical studies evaluating the targeting of stromal factors alone or in combination with immunotherapy based on immune checkpoint inhibitors. Finally, we discuss currently available strategies for the selective depletion of detrimental CAFs and for a better understanding of their interaction with NK cells and DCs.

Keywords: Cancer associated fibroblast (CAFs); Cell-cell interaction; Dendritic Cells; Immunotherapy; Natural Killer Cells; Solid tumors; Stromal Cell Therapy; Tumor microenvironment.

Publication types

  • Review

MeSH terms

  • Animals
  • Cancer-Associated Fibroblasts* / immunology
  • Cell Communication* / immunology
  • Dendritic Cells* / immunology
  • Humans
  • Immunotherapy* / methods
  • Killer Cells, Natural* / immunology
  • Neoplasms* / immunology
  • Neoplasms* / therapy
  • Tumor Microenvironment* / immunology